Antitumor cytotoxic T-cell response induced by a survivin peptide mimic

Michael J. Ciesielski; Manmeet S. Ahluwalia; Stephan A. Munich; Molly Orton; Tara Barone; Asher Chanan-Khan; Robert A. Fenstermaker

doi:10.1007/S00262-010-0845-X

Antitumor cytotoxic T-cell response induced by a survivin peptide mimic

Michael J. Ciesielski, Manmeet S. Ahluwalia, Stephan A. Munich, Molly Orton, Tara Barone, Asher Chanan-Khan, Robert A. Fenstermaker

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Cancer Immunology, Immunotherapy
Volume	59
DOIs	https://doi.org/10.1007/S00262-010-0845-X
State	Published - Apr 27 2010

Disciplines

Biology
Oncology

Access to Document

10.1007/S00262-010-0845-XLicense: Unspecified

Cite this

@article{da7508efdeaf44b7ae14cbcc7887f848,

title = "Antitumor cytotoxic T-cell response induced by a survivin peptide mimic",

author = "Ciesielski, \{Michael J.\} and Ahluwalia, \{Manmeet S.\} and Munich, \{Stephan A.\} and Molly Orton and Tara Barone and Asher Chanan-Khan and Fenstermaker, \{Robert A.\}",

note = "Survivin is a tumor-associated antigen with significant potential as a cancer vaccine target. We have identified a survivin peptide mimic containing human MHC class I epitopes and a potential class II ligand that induces a potent antitumor response in C57BL/6 mice with GL261 cerebral gliomas.",

year = "2010",

month = apr,

day = "27",

doi = "10.1007/S00262-010-0845-X",

language = "American English",

volume = "59",

journal = "Cancer Immunology, Immunotherapy",

}

TY - JOUR

T1 - Antitumor cytotoxic T-cell response induced by a survivin peptide mimic

AU - Ciesielski, Michael J.

AU - Ahluwalia, Manmeet S.

AU - Munich, Stephan A.

AU - Orton, Molly

AU - Barone, Tara

AU - Chanan-Khan, Asher

AU - Fenstermaker, Robert A.

N1 - Survivin is a tumor-associated antigen with significant potential as a cancer vaccine target. We have identified a survivin peptide mimic containing human MHC class I epitopes and a potential class II ligand that induces a potent antitumor response in C57BL/6 mice with GL261 cerebral gliomas.

PY - 2010/4/27

Y1 - 2010/4/27

UR - http://europepmc.org/articles/PMC4603658

U2 - 10.1007/S00262-010-0845-X

DO - 10.1007/S00262-010-0845-X

M3 - Article

VL - 59

JO - Cancer Immunology, Immunotherapy

JF - Cancer Immunology, Immunotherapy

ER -

Antitumor cytotoxic T-cell response induced by a survivin peptide mimic

Disciplines

Access to Document

Other files and links

Cite this